Lexaria Bioscience Ownership | Who Owns Lexaria Bioscience?


OverviewRevenueFinancialsChart

Lexaria Bioscience Ownership Summary


Lexaria Bioscience is owned by 4.97% institutional investors, 6.12% insiders, and 88.91% retail investors. Invenomic capital management lp is the largest institutional shareholder, holding 2.61% of LEXX shares. Invenomic Institutional is the top mutual fund, with 0.90% of its assets in Lexaria Bioscience shares.

LEXX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLexaria Bioscience4.97%6.12%88.91%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Invenomic capital management lp477.20K2.61%$454.63K
Murchinson419.59K2.29%$399.74K
Ubs group361.30K1.69%$222.92K
Vanguard group258.82K1.21%$159.69K
Geode capital management219.72K1.03%$135.59K
Toronto dominion bank140.01K0.77%$133.50K
Byrne asset management105.50K0.49%$65.09K
Raymond james financial services advisors48.80K0.35%$135.66K
State street39.30K0.21%$37.44K
Blackrock27.45K0.20%$76.30K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Murchinson419.59K0.05%$399.74K
Byrne asset management105.50K0.04%$65.09K
Invenomic capital management lp477.20K0.02%$454.63K
Virtu financial29.36K0.00%$28.00K
Krilogy financial19.65K0.00%$16.00K
Raymond james financial services advisors48.80K0.00%$135.66K
Toronto dominion bank140.01K0.00%$133.50K
Tower research capital llc (trc)3.62K0.00%$3.45K
Federation des caisses desjardins du quebec382.00-$233.00
Sound income strategies---

Top Buyers

HolderShares% AssetsChange
Murchinson419.59K0.05%419.59K
Ubs group361.30K-354.21K
Byrne asset management105.50K0.04%74.18K
Geode capital management219.72K-44.94K
Virtu financial29.36K0.00%29.36K

Top Sellers

HolderShares% AssetsChange
Sabby management---1.17M
Armistice capital---460.00K
Raymond james financial---61.25K
Gentrust---60.00K
Wealth enhancement advisory services---35.78K

New Positions

HolderShares% AssetsChangeValue
Murchinson419.59K0.05%419.59K$399.74K
Virtu financial29.36K0.00%29.36K$28.00K
Mai capital management200.00-200.00$124.00
Rockefeller capital management200.00-200.00$191.00
Morgan stanley3.00-3.00$2.00

Sold Out

HolderChange
Pnc financial services group-6.00
Northwestern mutual wealth management-9.00
Sound income strategies-22.00
Allworth financial lp-89.00
Mather group, llc.-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202514-44.00%1,062,180-38.15%45.64%7-46.15%--100.00%
Sep 30, 20252519.05%1,717,330-25.25%95.95%1344.44%2-
Jun 30, 202521-4.55%2,297,06385.28%1225.05%8-20.00%3-25.00%
Mar 31, 20251-96.00%549,947-61.85%34.20%1-92.31%--100.00%
Dec 31, 202425-7.41%1,426,41133.73%814.44%129.09%2-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Invenomic Institutional222.76K0.90%-4.07K
Vanguard Institutional Extnd Mkt Idx Tr154.45K0.62%-
Fidelity Extended Market Index123.49K0.50%38.65K
BlackRock Extended Equity Market K22.61K0.14%-10.00
Fidelity Total Market Index26.14K0.10%-
Blackrock Extended Mkt Fund CF25.94K0.10%25.94K
Spartan Extended Market Index Pool E17.81K0.10%755.00
Extended Equity Market Fund K22.25K0.09%14.00
Fidelity Series Total Market Index22.20K0.09%-
Spartan Extended Market Index Pool F21.06K0.08%163.00

Recent Insider Transactions


DateNameRoleActivityValue
Jul 30, 2025BUNKA CHRISTOPHER-Buy$10.87K
Jul 29, 2025BUNKA CHRISTOPHER-Buy$14.38K
Jul 29, 2025McKechnie William Edward-Buy$4.53K
Jul 29, 2025DOCHERTY JOHN MARTIN President & CSOBuy$4.99K
Jul 29, 2025Carle Vanessa SecretaryBuy$682.50

Insider Transactions Trends


DateBuySell
2025 Q36-
2025 Q2--
2025 Q1--
2024 Q311
2024 Q2--

LEXX Ownership FAQ


Who Owns Lexaria Bioscience?

Lexaria Bioscience shareholders are primarily institutional investors at 4.97%, followed by 6.12% insiders and 88.91% retail investors. The average institutional ownership in Lexaria Bioscience's industry, Biotech Stocks , is 381.47%, which Lexaria Bioscience falls below.

Who owns the most shares of Lexaria Bioscience?

Lexaria Bioscience’s largest shareholders are Invenomic capital management lp (477.2K shares, 2.61%), Murchinson (419.59K shares, 2.29%), and Ubs group (361.3K shares, 1.69%). Together, they hold 6.59% of Lexaria Bioscience’s total shares outstanding.

Does Blackrock own Lexaria Bioscience?

Yes, BlackRock owns 0.20% of Lexaria Bioscience, totaling 27.44K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 76.3K$. In the last quarter, BlackRock increased its holdings by 25.94K shares, a 1719.96% change.

Who is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested?

Murchinson is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 419.59K Lexaria Bioscience shares, valued at 399.74K$.

Who is the top mutual fund holder of Lexaria Bioscience shares?

Invenomic Institutional is the top mutual fund holder of Lexaria Bioscience shares, with 0.90% of its total shares outstanding invested in 222.76K Lexaria Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools